This underscores the role of CD8+ T cells in promoting tumor cell ferroptosis and suggests that targeting the XCT/GSH/GPX4 pathway in combination with anti‐PD‐1/PD‐L1 antibodies may represent an effective tumor immunotherapy strategy [19]. The gene discussed is SLC7A11; the disease is neoplasm.